Windlas Biotech Limited

NSEI:WINDLAS Voorraadrapport

Marktkapitalisatie: ₹22.9b

Windlas Biotech Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Komal Gupta

Algemeen directeur

₹16.5m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO9.1yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn4.6yrs
Gemiddelde ambtstermijn bestuur4.5yrs

Recente managementupdates

Recent updates

Windlas Biotech Limited's (NSE:WINDLAS) 30% Share Price Surge Not Quite Adding Up

Nov 01
Windlas Biotech Limited's (NSE:WINDLAS) 30% Share Price Surge Not Quite Adding Up

Windlas Biotech (NSE:WINDLAS) Will Pay A Larger Dividend Than Last Year At ₹5.50

Sep 01
Windlas Biotech (NSE:WINDLAS) Will Pay A Larger Dividend Than Last Year At ₹5.50

Windlas Biotech Limited (NSE:WINDLAS) Stock Rockets 26% But Many Are Still Ignoring The Company

Aug 13
Windlas Biotech Limited (NSE:WINDLAS) Stock Rockets 26% But Many Are Still Ignoring The Company

Should You Be Adding Windlas Biotech (NSE:WINDLAS) To Your Watchlist Today?

Jul 30
Should You Be Adding Windlas Biotech (NSE:WINDLAS) To Your Watchlist Today?

Even With A 27% Surge, Cautious Investors Are Not Rewarding Windlas Biotech Limited's (NSE:WINDLAS) Performance Completely

Jun 07
Even With A 27% Surge, Cautious Investors Are Not Rewarding Windlas Biotech Limited's (NSE:WINDLAS) Performance Completely

Is Now The Time To Put Windlas Biotech (NSE:WINDLAS) On Your Watchlist?

Nov 03
Is Now The Time To Put Windlas Biotech (NSE:WINDLAS) On Your Watchlist?

Windlas Biotech (NSE:WINDLAS) Is Increasing Its Dividend To ₹4.00

Aug 20
Windlas Biotech (NSE:WINDLAS) Is Increasing Its Dividend To ₹4.00

Windlas Biotech (NSE:WINDLAS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

May 23
Windlas Biotech (NSE:WINDLAS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Windlas Biotech Limited's (NSE:WINDLAS) Shares Lagging The Market But So Is The Business

Apr 07
Windlas Biotech Limited's (NSE:WINDLAS) Shares Lagging The Market But So Is The Business

CEO

Komal Gupta

9.1yrs

Tenure

₹16,530,000

Compensatie

Mrs. Komal Gupta is the Chief Financial Officer of Windlas Biotech Limited since October 16, 2015 and serves as its Chief Executive Officer since February 08, 2023. She joined Windlas Biotech on October 16...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Komal Gupta
CFO & CEO9.1yrs₹16.53mgeen gegevens
Ananta Panda
Company Secretary & Compliance Officer3.6yrs₹2.52mgeen gegevens
Ashok Windlass
Whole-Time Directorno data₹15.60m62.51%
₹ 14.3b
Hitesh Windlass
MD & Executive Director4.6yrs₹17.50m0.000010%
₹ 2.3k
Manoj Windlass
Joint MD & Executive Director4.6yrs₹17.50m0.000030%
₹ 6.9k
Pawan Sharma
Executive Directorno data₹5.07mgeen gegevens
Mohammed Aslam
President of Sales & Marketingno datageen gegevensgeen gegevens
Om Sule
Site Quality Head4.9yrsgeen gegevensgeen gegevens

4.6yrs

Gemiddelde duur

55.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van WINDLAS wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.6 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Ashok Windlass
Whole-Time Director23.8yrs₹15.60m62.51%
₹ 14.3b
Hitesh Windlass
MD & Executive Director16.8yrs₹17.50m0.000010%
₹ 2.3k
Manoj Windlass
Joint MD & Executive Director18.6yrs₹17.50m0.000030%
₹ 6.9k
Pawan Sharma
Executive Director5.4yrs₹5.07mgeen gegevens
Gaurav Gulati
Non-Executive Independent Director3.5yrs₹540.00kgeen gegevens
Vivek Dhariwal
Non-Executive Independent Chairman3.5yrs₹380.00kgeen gegevens
Srinivasan Venkataraman
Non-Executive Independent Director3.5yrs₹450.00kgeen gegevens
Prachi Windlass
Non-Executive Director3.5yrsgeen gegevens0.000010%
₹ 2.3k

4.5yrs

Gemiddelde duur

49yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van WINDLAS wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.5 jaar).